网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
急性白血病化疗患儿医院感染的影响因素分析及防控策略研究
作者:陈俐  傅彩红 
单位:南京医科大学附属儿童医院 313病区血液肿瘤科, 江苏 南京 210000
关键词:急性白血病 化疗 医院感染 影响因素 
分类号:R733.71
出版年·卷·期(页码):2024·52·第二期(209-214)
摘要:

目的:探讨急性白血病(AL)化疗患儿医院感染有关影响因素,分析防控策略。方法:选取2020年3月至2022年3月我院收治的AL化疗患儿155例,回顾性分析患儿住院期间医院感染情况及其他相关临床资料。应用单因素与多因素Logistic回归分析探讨AL化疗患儿出现医院感染的影响因素;采用受试者工作特征(ROC)曲线分析多因素Logistic各独立影响因素与联合预测因子对患儿出现医院感染的预测效能;并以交叉验证法检验联合预测因子预测价值。结果:155例AL化疗患儿医院感染发生率为30.97%。多因素Logistic回归分析显示,化疗阶段为诱导缓解期、有皮肤黏膜损害、住院时间长均为患儿出现医院感染的独立危险因素,中性粒细胞计数高、白蛋白水平高均为患儿出现医院感染的独立保护因素(P<0.05);ROC曲线分析显示,各独立影响因素(化疗阶段为诱导缓解期、有皮肤黏膜损害、住院时间长、中性粒细胞计数、白蛋白水平高)对患儿出现医院感染均有一定预测效能,曲线下面积(AUC)分别为0.638、0.710、0.813、0.785、0.716;联合预测因子的预测AUC为0.928,标准误为0.022,95%CI 0.884~0.971,约登指数为0.729,P<0.001;使用交叉验证法检验显示,联合预测因子分类准确率为88.39%。结论:AL化疗患儿医院感染影响因素包括化疗阶段为诱导缓解期、有皮肤黏膜损害、住院时间长、中性粒细胞计数高、白蛋白水平高,且上述因素联合对患儿医院感染的预测效能良好,可为防控对策制定提供指导。

Objective: To explore the influencing factors of nosocomial infection in children with acute leukemia(AL) undergoing chemotherapy, and to analyze the prevention and control strategies. Methods: A total of 155 children with AL undergoing chemotherapy admitted to the hospital from March 2020 to March 2022 were selected, and the nosocomial infection and other related clinical data during hospitalization were retrospectively analyzed.Univariate and multivariate Logistic regression analysis were used to explore the influencing factors of nosocomial infection in children with AL undergoing chemotherapy. The receiver operating characteristic(ROC) curve was used to analyze the predictive efficacy of independent influencing factors and combined predictors of multivariate Logistic on nosocomial infection in children. The predictive value of combined predictors was tested by cross validation. Results: The incidence of nosocomial infection in 155 children with AL undergoing chemotherapy was 30.97%. Multivariate Logistic regression analysis showed that chemotherapy stage as induction remission stage, skin and mucosal damage, and long hospitalization time were independent risk factors for nosocomial infection in children. High neutrophil count and albumin level were independent protective factors for nosocomial infection in children(P<0.05). ROC curve analysis showed that each independent influencing factor(chemotherapy stage as induction remission stage, skin and mucosal damage, long hospitalization time, high neutrophil count, high albumin level) had certain predictive efficacy for nosocomial infection in children, and area under curve(AUC) were 0.638, 0.710, 0.813, 0.785, 0.716 respectively. The prediction AUC of the combined predictor was 0.928, the standard error was 0.022, 95%CI 0.884-0.971, and the Yoden index was 0.729, P<0.001. The cross validation test showed that the classification accuracy of joint predictors was 88.39%. Conclusion: The influencing factors of nosocomial infection in children with AL undergoing chemotherapy include chemotherapy stage as induction remission stage, skin and mucosal damage, long hospitalization time, high neutrophil count and albumin level, and the combination of the above factors has a good predictive effect on nosocomial infection in children, which could provide guidance for the formulation of prevention and control countermeasures.

参考文献:

[1] SMITH L,GLASER A W,KINSEY S E,et al.Long-term survival after childhood acute lymphoblastic leukaemia:population-based trends in cure and relapse by clinical characteristics[J].Br J Haematol,2018,182(6):851-858.
[2] 曹彤,阳艳丽.急性淋巴细胞白血病患儿院内感染的病原菌分布及耐药性分析[J].新乡医学院学报,2020,37(2):173-176.
[3] HAKIM H,DALLAS R,WOLF J,et al.Gut microbiome composition predicts infection risk during chemotherapy in children with acute lymphoblastic leukemia[J].Clin Infect Dis,2018,67(4):541-548.
[4] CHABER R,LATOS-GRAYSKA E,CIEBIERA K,et al.Body mass index(BMI) and infectious/febrile episodes in children with intermediate risk acute lymphoblastic leukemia(IR ALL)[J].Nutr Cancer,2019,71(4):701-707.
[5] 翟岩,郭文静,范慧.急性白血病患儿化疗期间院内感染的临床特点及Logistic回归分析[J].实用癌症杂志,2023,38(4):694-696.
[6] 万建培,陈纯,金润铭,等.儿童急性白血病的诊断与治疗[M].北京:人民卫生出版社,2008:144-150.
[7] 中华人民共和国卫生部.医院感染诊断标准(试行)[J].中华医学杂志,2001,81(5):314-320.
[8] 贠淑茸,孙文华.756例急性白血病化疗患儿医院感染危险因素分析及预防控制策略[J].医学临床研究,2021,38(7):1081-1083.
[9] 高珊,屈丽君,陈天平.92例儿童急性淋巴细胞白血病首次诱导化疗合并感染临床分析[J].安徽医学,2022,43(7):813-816.
[10] 张鹏鹏,王丽娜,李明,等.恶性血液病粒细胞缺乏症患者医院感染的临床特征及危险因素分析[J].中国实验血液学杂志,2020,28(2):669-676.
[11] 魏同,毛夏丽,周琪,等.急性白血病粒细胞缺乏症患者医院感染的临床特征及影响因素研究[J].临床血液学杂志,2020,33(9):634-639.
[12] 文萍,雷小琴,胡亚莉,等.急性白血病患儿血流感染预测模型的构建与验证[J].护理研究,2021,35(22):3949-3953.
[13] 崔清彦,张婷,陈森.儿童急性淋巴细胞白血病化疗后感染的临床特征及危险因素分析[J].中国现代医学杂志,2020,30(23):72-76.
[14] 赵继鸥,袁玉芳,张荣荣,等.儿童急性淋巴细胞白血病诱导缓解化疗期间院内感染危险因素分析[J].华西医学,2019,34(4):370-374.
[15] NGOLET L O,BOLENGA LIBOKO A F,OSSIBI IBARA B R,et al.Hospital acquired infection in a department of hematology-oncology care in the Congo[J].Am J Blood Res,2021,11(2):191-198.
[16] 张利萍,陈红英,胡晓,等.儿童急性淋巴细胞白血病化疗期间感染及脓毒症的临床诊治分析[J].解放军医学院学报,2019,40(7):618-623.
[17] CARVALHO A S,LAGANA D,CATFORD J,et al.Bloodstream infections in neutropenic patients with haematological malignancies[J].Infect Dis Health,2020,25(1):22-29.
[18] 唐晶,张荣,李冬梅.急性髓系白血病患者化疗后院内感染危险因素及护理措施分析[J].现代医学,2020,48(11):1448-1451.
[19] 李婷,兰义芬,薛武进,等.急性白血病感染患者炎症因子、凝血指标及血小板参数的相关性分析[J].中国卫生检验杂志,2019,29(7):847-850.
[20] LIN J L,LIU K K,CHU J H,et al.Relationship between nutritional status and nosocomial infection in children with acute lymphoblastic leukemia[J].J Exp Hematol,2020,28(3):767-774.
[21] BANERJEE J,NIINIMÄKI R,LÄHTEENMÄKI P,et al.The spectrum of acute central nervous system symptoms during the treatment of childhood acute lymphoblastic leukaemia[J].Pediatr Blood Cancer,2020,67(2):e27999.
[22] SANO H,KOBAYASHI R,SUZUKI D,et al.Impact of the D-index deduced from duration and intensity of neutropenia following chemotherapy on the risk of invasive fungal infection in pediatric acute myeloid leukemia[J].Int J Hematol,2018,108(1):85-90.
[23] LIANG R,CHEN G Y,FU S X,et al.Benefit of oral nutritional supplements for children with acute lymphoblastic leukaemia during remission-induction chemotherapy:a quasi-experimental study[J].Asia Pac J Clin Nutr,2018,27(1):144-147.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 749939 位访问者


 ©《现代医学》编辑部
联系电话:025-83272481;83272479
电子邮件: xdyx@pub.seu.edu.cn

苏ICP备09058541